Afebrile Pneumonia Syndrome Clinical Presentation

  • Author: Robert W Tolan Jr, MD; Chief Editor: Michael R Bye, MD   more...
 
Updated: Mar 29, 2011
 

History

Early symptoms of respiratory disease in neonates and infants are frequently nonspecific and include changes in feeding status, listlessness, irritability, and poor color. Onset may be acute or subacute. Typically, infants are afebrile or have only a low-grade fever (< 102°F).

Viral afebrile pneumonia syndrome (APS) typically has a more rapid onset, with a 1- to 2-day history of rhinorrhea and, often, a brassy cough. Nonspecific findings of poor feeding, lethargy, and irritability may be accompanied by congestion, apnea (uncommon), and cyanosis (rare).

Symptoms of APS from Chlamydia trachomatis typically begin at age 2-19 weeks. Onset is insidious, often occurring over several days to weeks. No signs of systemic illness are apparent, but infants with mild-to-moderate illness often have a repetitive staccato cough (inspiration between each single cough).[6] A history of conjunctivitis (which may be concurrent) increases the possibility of chlamydial infection.[7]

Ureaplasma urealyticum

U urealyticum is typically associated with prematurity and chronic lung disease. U urealyticum has been routinely isolated from the lower respiratory tract and lung biopsy specimens from infants with low birthweight, premature infants with pneumonia, and infants younger than 3 months who have chronic lung disease. Nevertheless, the role of this organism in development of lower respiratory tract infections in other infants remains unclear. Infection may manifest in this population as chronic lung disease, acute deterioration, or subacute deterioration in lung function.

Cytomegalovirus

Clinical manifestations of disease from CMV vary with the age and immunologic status of the child. Although infection following vertical transmission is usually not associated with clinical illness, maternal cervical colonization commonly occurs; therefore, many infants are exposed at birth. Cervical excretion rates are highest among young mothers in lower socioeconomic groups. Most infants infected are asymptomatic, but some may develop interstitial pneumonitis in early infancy. Because CMV infection is common in newborns, its association with afebrile pneumonia has been questioned. Symptoms are typically not distinguishable from those in APS from other causes.

Respiratory syncytial virus

RSV is likely the most common cause of afebrile pneumonia in young infants, although it more frequently causes febrile pneumonia or bronchiolitis, since the incidence of chlamydial APS seems to be decreasing. Peak age of onset is 2-5 months. Infection during the first few weeks of life may produce minimal respiratory signs. Lethargy, irritability, and poor feeding (which signal a possible illness in any young infant) accompanied by periods of apnea may be the major manifestations of infection. Most infants do not require hospitalization. However, the illness can be severe or fatal in some infants, particularly if associated with cyanotic or congenital heart disease, prematurity, or immunodeficiency due to disease or immunosuppressive therapy.

RSV infection is usually epidemic during the winter and early spring months, primarily affects children in the first 3 years of life, and is spread horizontally by household or childcare center contacts. Although wheezing and typical bronchiolitis may be noted, nonspecific symptoms more typical of APS may predominate.

Adenovirus

Adenovirus is an infrequent cause of croup and bronchiolitis. In infancy, adenovirus can cause severe pneumonia, which may disseminate, resulting in death. Infants may present with conjunctivitis, pharyngitis, respiratory tract symptoms, and, possibly, gastrointestinal tract disturbances. Less commonly, adenoviral disease may result in more typical APS.

Parainfluenza virus

Parainfluenza virus infections may be epidemic or sporadic. Type 1 occurs every other fall and manifests as croup. Type 2 also occurs in the fall, but disease is typically less severe than that caused by type 1. Type 3 infection occurs in the spring and summer and is usually acquired during the first 2 years of life; it is also a major cause of lower respiratory tract infection. Repeat infection may occur at any age and is usually milder, resulting in upper respiratory tract infections. Individuals with immunodeficiency can develop severe lower respiratory tract infection with prolonged viral shedding. Secondary bacterial infections are common after viral disease. Rarely, apnea may occur in infants younger than 6 months and may necessitate short-term apnea monitoring. Otherwise, APS secondary to infection by parainfluenza virus may be clinically indistinguishable from APS that results from other causes.

Pneumocystis jiroveci

P jiroveci, a pathogen related to fungi, is best known as a cause of opportunistic disease in immunocompromised individuals. Recently, it has also been associated with afebrile pneumonia in immunocompetent infants. Approximately 75% of healthy persons acquire antibody to P jiroveci by age 4 years. Onset of symptoms during the first month of life is rare; peak incidence of infection is from age 2-6 months. The mode of transmission of P jiroveci is unknown. Typically, infection is asymptomatic, but it may cause APS in a small percentage of infants who are exposed to the pathogen.

Next

Physical Examination

Signs of APS are typically nonspecific, and considerable overlap occurs among the various causes. Rarely, infants may display lethargy or irritability and poor color.

Respiratory findings may include cough, tachypnea, and crackles. Cough, which may be staccato (particularly in C trachomatis infection), is nearly universal. Tachypnea and crackles are usually present. In APS caused by C trachomatis, auscultatory findings may be out of proportion to the overall healthy appearance of the infant.

Respiratory distress is typically only mild to moderate and may include the following:

  • Retractions
  • Grunting
  • Flaring

Apnea is uncommon. Cyanosis is rare.

Other pulmonary findings are possible but uncommon and may include the following:

  • Decreased aeration
  • Dullness to percussion
  • Wheezing

Conjunctivitis suggests C trachomatis infection (present concurrently or in the history in half of cases). GI tract, conjunctival, or pharyngeal involvement may suggest adenovirus infection. Concomitant hepatosplenomegaly or lymphadenopathy may suggest CMV infection.

Previous
Next

Risk Factors

Factors that are associated with increased risk of contracting APS in infants include the following:

  • Low socioeconomic status
  • Young maternal age
  • Multiple maternal sex partners
  • Unmarried maternal status
  • Exposure to other children at home or in daycare
  • Exposure to secondhand smoke
Previous
Next

Complications

Secondary bacterial infection may occur, particularly with viral disease.

Previous
 
 
Contributor Information and Disclosures
Author

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Sanofi Pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

Coauthor(s)

Judith R Grisi, PA-C  Physician Assistant, Monmouth Ocean Pulmonary Medicine, CentraState Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Susanna A McColley, MD  Associate Professor, Department of Pediatrics, Northwestern University, The Feinberg School of Medicine; Director of Cystic Fibrosis Center, Head, Division of Pulmonary Medicine, Children's Memorial Medical Center of Chicago

Susanna A McColley, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Sleep Disorders Association, and American Thoracic Society

Disclosure: Genentech Honoraria Speaking and teaching; Genentech Honoraria Consulting; Boston Scientific Consulting fee Consulting; Gilead Honoraria Speaking and teaching; Caremark Consulting fee Consulting; Vertex Pharmaceuticals Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

Heidi Connolly, MD  Associate Professor of Pediatrics and Psychiatry, University of Rochester; Director, Pediatric Sleep Medicine Services, Strong Sleep Disorders Center

Heidi Connolly, MD is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Chief Editor

Michael R Bye, MD  Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Brewster DR, De Silva LM, Henry RL. Chlamydia trachomatis and respiratory disease in infants. Med J Aust. Oct 3 1981;2(7):328-30. [Medline].

  2. Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr. Jan 2010;156(1):115-20. [Medline].

  3. Brasfield DM, Stagno S, Whitley RJ, et al. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. Jan 1987;79(1):76-83. [Medline].

  4. Fasoli L, Paldanius M, Don M, et al. Simkania negevensis in community-acquired pneumonia in Italian children. Scand J Infect Dis. 2008;40(3):269-72. [Medline].

  5. Chen CJ, Wu KG, Tang RB, Yuan HC, Soong WJ, Hwang BT. Characteristics of Chlamydia trachomatis infection in hospitalized infants with lower respiratory tract infection. J Microbiol Immunol Infect. Jun 2007;40(3):255-9. [Medline].

  6. Beem MO, Saxon E, Tipple MA. Treatment of chlamydial pneumonia of infancy. Pediatrics. Feb 1979;63(2):198-203. [Medline].

  7. Radkowski MA, Kranzler JK, Beem MO, et al. Chlamydia pneumonia in infants: radiography in 125 cases. AJR Am J Roentgenol. Oct 1981;137(4):703-6. [Medline].

  8. Geis T, Schilling S, Segerer H. [A Young Infant with Afebrile Pneumonia Caused by Chlamydia Trachomatis]. Klin Padiatr. Aug 3 2006;[Medline].

  9. Abzug MJ, Beam AC, Gyorkos EA, Levin MJ. Viral pneumonia in the first month of life. Pediatr Infect Dis J. Dec 1990;9(12):881-5. [Medline].

  10. FDA Approves Roche (RHHBY)'s Valcyte(R) to Prevent Cytomegalovirus Disease in Pediatric Patients Who Receive Heart or Kidney Transplants. Available at http://www.biospace.com/news_story.aspx?NewsEntityId=154407. Accessed November 12, 2010.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.